IP Library Assignment 018917/0374
Patent Assignment
Reel/Frame 018917/0374

Change of Name

Recorded: 2007-02-20 Pages: 6
Assignor
Assignee
PROSPECT PHARMACEUTICALS, INC.
174 MARLBOROUGH STREET, BOSTON, MASSACHUSETTS, 02116
Covered Properties (17)
Delivery System and Methods for Gene Therapy
Patent: 6,500,807 →
Application: 09/495,675 →
Method and material for treating immune diseases
Application: 10/176,022 →
Publication: US 2003/0004132
Method for Enhancing the Effectiveness of Cancer Therapies
Patent: 6,680,306 →
Application: 10/176,235 →
Publication: US 2003/0013681
Method for Controlling Angiogenesis in Animals
Patent: 6,890,906 →
Application: 10/299,478 →
Publication: US 2003/0100535
Method for enhancing the effectiveness of therapies of hyperproliferative diseases
Application: 10/408,723 →
Publication: US 2004/0023925
Method for enhancing the effectiveness of cancer therapies
Application: 10/657,383 →
Publication: US 2004/0043962
Method for controlling angiogenesis in animals
Application: 10/665,055 →
Publication: US 2004/0121981
Composition and uses of galectin antagonists
Application: 10/819,901 →
Publication: US 2004/0223971
Modified Pectins, Compositions and Methods Related Thereto
Patent: 8,128,966 →
Application: 11/093,268 →
Publication: US 2005/0250735
Composition and method for treating hyperproliferative diseases
Application: 11/181,201 →
Publication: US 2006/0074050
Method for enhancing the effectiveness of cancer therapies
Application: 60/299,991 →
Method and material for treating immune diseases
Application: 60/300,360 →
Method for controlling angiogenesis in animals
Application: 60/331,793 →
Composition and uses of galectin antagonists
Application: 60/461,006 →
Composition and uses of galectin antagonists
Application: 60/474,562 →
Modified pectins, compositions and methods related thereto
Application: 60/556,674 →
Composition and method for treating hyperproliferative diseases
Application: 60/588,608 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2004
From: CHANG, YAN; SASAK, VODEK
To: GLYCOGENESYS, INC.
Reel/Frame 014371/0329 →
Assignment of Assignor's Interest Jun 23, 2004
From: STAPLES, MARK; ROLKE, JAMES
To: GLYCOGENESYS, INC.
Reel/Frame 014769/0327 →
Assignment of Assignor's Interest Oct 22, 2004
From: CHANG, YAN
To: GLYCOGENESYS, INC.
Reel/Frame 015282/0736 →
Assignment of Assignor's Interest Oct 22, 2004
From: CHANG, YAN; SASAK, VODEK
To: GLYCOGENESYS, INC.
Reel/Frame 015282/0927 →
Assignment of Assignor's Interest Jul 25, 2005
From: STAPLES, MARK; ROLKE, JAMES
To: GLYCOGENESYS, INC.
Reel/Frame 016568/0411 →
Assignment of Assignor's Interest Aug 19, 2005
From: CHANG, YAN; SASAK, VODEK
To: GLYCOGENESYS, INC.
Reel/Frame 016652/0688 →
Assignment of Assignor's Interest Dec 14, 2005
From: CHANG, YAN; COTTER, FINBARR
To: GLYCOGENESYS, INC.
Reel/Frame 017355/0916 →
Assignment of Assignor's Interest Jan 17, 2007
From: DEGIACOMO, MARK G., CHAPTER 7 TRUSTEE, GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT INC.
Reel/Frame 018777/0643 →
Change of Name Feb 20, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 018917/0395 →
Assignment of Assignor's Interest Feb 20, 2007
From: DEGIACOMO, MARK G., CHAPTER 7 TRUSTEE GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT INC.
Reel/Frame 018917/0380 →
Employment Agreement Dec 7, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 020227/0030 →
Change of Name Dec 10, 2007
From: SAFESCIENCE INC.
To: GLYCOGENESYS, INC.
Reel/Frame 020227/0796 →
Notice of Attorney's Lien Jun 18, 2009
From: PROSPECT THERAPEUTICS, INC.
To: ROPES & GRAY LLP
Reel/Frame 022846/0200 →
Release of Attorney's Lien Sep 23, 2009
From: ROPES & GRAY LLP
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 023273/0037 →
Asset Purchase Agreement Mar 19, 2010
From: TANG CAPITAL PARTNERS LP
To: SOLANA THERAPEUTICS, INC.
Reel/Frame 024103/0764 →
Assignment of Assignor's Interest Mar 19, 2010
From: PROSPECT PHARMACEUTICALS, INC.
To: TANG CAPITAL PARTNERS LP
Reel/Frame 024103/0753 →
Assignment of Assignor's Interest Mar 22, 2010
From: PROSPECT THERAPEUTICS, INC.
To: TANG CAPITAL PARTNERS L.P.
Reel/Frame 024114/0769 →
Assignment of Assignor's Interest Jan 24, 2012
From: SOLANA THERAPEUTICS, INC.
To: LA JOLLA PHARMACEUTICAL COMPANY
Reel/Frame 027583/0268 →
Merger Jun 29, 2012
From: LA JOLLA PHARMACEUTICAL COMPANY
To: LJPC MERGER SUB, INC.
Reel/Frame 028467/0776 →
Change of Name Jul 3, 2012
From: LJPC MERGER SUB, INC.
To: LA JOLLA PHARMACEUTICAL COMPANY
Reel/Frame 028484/0884 →
Assignment of Assignor's Interest Sep 9, 2016
From: PROSPECT THERAPEUTICS, INC.
To: TANG CAPITAL PARTNERS LP
Reel/Frame 039981/0127 →
Merger and Change of Name Oct 12, 2016
From: LJPC MERGER SUB, INC.; LA JOLLA PHARMACEUTICAL COMPANY
To: LA JOLLA PHARMCEUTICAL COMPANY
Reel/Frame 039998/0504 →
Merger Oct 12, 2016
From: LA JOLLA PHARMACEUTICAL COMPANY
To: LJPC MERGER SUB, INC.
Reel/Frame 039998/0275 →
Assignment of Assignor's Interest Oct 12, 2016
From: SOLANA THERAPEUTICS, INC.
To: LA JOLLA PHARMACEUTICAL COMPANY
Reel/Frame 039997/0262 →
Assignment of Assignor's Interest Oct 12, 2016
From: TANG CAPITAL PARTNERS LP
To: SOLANA THERAPEUTICS, INC.
Reel/Frame 039997/0227 →